Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1960 1
1961 3
1962 2
1963 3
1966 1
1967 3
1968 8
1969 6
1970 2
1971 3
1972 5
1973 4
1974 11
1975 15
1976 10
1977 12
1978 15
1979 15
1980 22
1981 17
1982 30
1983 20
1984 15
1985 28
1986 26
1987 29
1988 16
1989 27
1990 27
1991 20
1992 30
1993 38
1994 36
1995 25
1996 32
1997 33
1998 38
1999 44
2000 43
2001 40
2002 56
2003 49
2004 42
2005 39
2006 42
2007 31
2008 25
2009 22
2010 26
2011 25
2012 26
2013 21
2014 25
2015 21
2016 29
2017 36
2018 31
2019 18
2020 28
2021 15
Text availability
Article attribute
Article type
Publication date

Search Results

1,301 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M; Post RAISE group. Miyata K, et al. Among authors: matsushima t. Lancet Child Adolesc Health. 2018 Dec;2(12):855-862. doi: 10.1016/S2352-4642(18)30293-1. Epub 2018 Oct 16. Lancet Child Adolesc Health. 2018. PMID: 30337183
The history of Rhoton's Lab.
Matsushima T, Richard Lister J, Matsushima K, de Oliveira E, Timurkaynak E, Peace DA, Kobayashi S. Matsushima T, et al. Neurosurg Rev. 2019 Mar;42(1):73-83. doi: 10.1007/s10143-017-0902-4. Epub 2017 Sep 6. Neurosurg Rev. 2019. PMID: 28879421 Review.
Multifocal Infantile Hemangioma.
Uda K, Okubo Y, Matsushima T, Sadahira C, Kono T, Hataya H. Uda K, et al. Among authors: matsushima t. J Pediatr. 2019 Jul;210:238-238.e1. doi: 10.1016/j.jpeds.2019.02.048. Epub 2019 Apr 5. J Pediatr. 2019. PMID: 30955789 No abstract available.
Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage.
Yamamoto Y, Matsui J, Matsushima T, Obaishi H, Miyazaki K, Nakamura K, Tohyama O, Semba T, Yamaguchi A, Hoshi SS, Mimura F, Haneda T, Fukuda Y, Kamata JI, Takahashi K, Matsukura M, Wakabayashi T, Asada M, Nomoto KI, Watanabe T, Dezso Z, Yoshimatsu K, Funahashi Y, Tsuruoka A. Yamamoto Y, et al. Among authors: matsushima t. Vasc Cell. 2014 Sep 6;6:18. doi: 10.1186/2045-824X-6-18. eCollection 2014. Vasc Cell. 2014. PMID: 25197551 Free PMC article.
1,301 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page